Lightcalls.com
 

The Original Pioneers: A Written & ...

The Original Pioneers: A Written & Photographic Essay

The Man onward Cancer

Since 1971 when President Nixon's official "War onward Cancer" was declared, the U has exhausted over $1.5 trillion on conventional cancer research and treatment.

Unfortunately, as medical journal articles have confirmed, the sight for most people diagnosed with cancer today, with more [i]or[/i] less exceptions, is not much better than it was a generation ago.

Increasingly, confidence in the fight against cancer is coming from complementary alternative medicine. Cancer patients' interest in alternative therapies these days is at an all-time high, with almost 50 percent of patients using the same or more alternatives. And finally there is serious interest forward the part of the conventional medical community.

Remembering the pioneers



As of recent origin doors open, it is important not to supervise the original pioneers of alternative cancer therapies -- a relatively small dispose of far-sighted and high-spirited individuals who faced great adversity and overcame daunting not divisible by 2s to make significant, and on a level landmark, contributions.

on the middle of the 20th centenary medical treatments in the U were limited to options like put drugs intos surgery, antibiotics, and radiation. mostly practitioners of natural medicine, including homeopaths and naturopaths, had been driven subterranean -- or out of practice. During that dark period for medical freedom, the alternative cancer therapy pioneers largely kept chance of a favorable result alive for all of natural medicine in the form of traditionally based, natural, and holistic cancer treatments.

Many of the alternative cancer pioneers worked in the field of clinical nutrition. Although the make liable of diet and cancer was widely researched through mainstream medicine during the 1930 and '40 the discoveries were not applied to patients.

Max Gerson MD single in kind clinician who did believe in using diet to treat cancer was Max Gerson MD A refugee from Nazi Germany, Gerson settl in strange York City in the mid-1930s. He experimented with an innovative nutritional regimen to treat population seriously ill with cancer and other degenerative diseases.

Gerson pioneered a low-fat, fiber-rich, largely vegetarian diet, continuationed with massive amounts of micronutrients (contained in a dozen glasses by day of freshly prepared organic vegetable juices). He also reinforced the ne to detoxify the visible form [i]or[/i] frame and introduced the use of coffee enemas to cleanse the liver.

The nearest generation

Gerson's death in 1959 might have clos the work on his promising work, further many of his contributions were adapted and occupyed by a new generation of alternative cancer specialists, including

William Donald Kelley DDS

Kelley who was active from the late 1960 within the mid-1980s, emphasized metabolic individuality, or metabolic typing.

His theory held that no single therapy, diet, or postscript -- no matter how beneficial -- is perfect for everyone because each person's biochemistry is totally unique and different.

In order to assess a person's individual "metabolic type" Kelley devised elaborate questionnaires and proofs and was an early adopter of sophisticated computer technology to evaluate the springs Kelley identified enzymes as critically important and did research forward the influence of genetics onward the autonomic nervous system.

The goal of Kelley's therapy, which included a specific diet, nutritional fill ups and detoxification, was to achieve an ideal metabolic balance that would enable the corpse to heal itself. Like Gerson's, a great quantity [i]or[/i] amount of of Kelley's work has been adapted at alternative cancer clinicians today.

`Buzzword' of the 70s: Laetrile therapy

Twenty years ago, the main "buzzword" in the field of alternative cancer therapy was laetrile. Although dismissed on the medical Establishment, laetrile delineateed the tip of the iceberg of a revolution in the one and the other the clinical practice and the politics of alternative cancer medicine.

Sometimes called amygdalin or vitamin B-17 laetrile is a nutritional substance derived from certain plants and germs In the 1950s, it was used through itself to treat people with cancer. by way of the 1970s, laetrile therapy had expanded to include diet, detoxification, digestive enzyme and other fill ups -- as well as cluster support therapy and attention to a patient's spiritual needs

The emerging see the verb of this holistic, "metabolic" approach to treatment had tremendous ramifications for alternative medicine as a whole.

Meanwhile, the banning of laetrile helped to inspire a high-profile grassroots motion for freedom of healthcare choice that had vivid and lasting effects on national medical policy and the public's expectations of medical freedom in a democratic society.

Ernesto Contreras, MD

single in kind of the principal proponents of laetrile is Ernesto Contreras, MD

from beginning to end the 1970s, Contreras was the reassuring human face the North American media place on the scores of alternative cancer clinics that had sprung up in Tijuana, Mexico. Thousands of American citizens with cancer have traveled to Contreras and the other popular Tijuana cancer clinics for treatments that are not legally available at hearth Contreras has reported, always conservatively, positive rises in the thousands of patients he has treated.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.